Embecta (EMBC) Net Margin (2020 - 2026)

Embecta (EMBC) posted Net Margin of 1.85% for Q1 2026, down 110.95% sequentially from 16.88% in Q4 2025, and down 1092.0% YoY from 0.19% in Q1 2025.

Embecta (EMBC) Net Margin (2020 - 2026) Analysis & Trends

Embecta has reported Net Margin for 7 years, with the latest figure at 1.85% in Q1 2026.

Quarterly Net Margin fell 1092.0% year-over-year to 1.85% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 10.73% (up 584.0% YoY) and the FY2025 annual result came in at 8.83%, up 186.0% from the prior year.
Net Margin slipped to 1.85% in Q1 2026 per EMBC's latest filing, from 16.88% in the prior quarter.
Over five years, Net Margin peaked at 29.0% in Q1 2022 and troughed at 6.26% in Q3 2022.
A 5-year average of 9.17% and a median of 8.16% in 2023 frame the typical range for Net Margin.
The sharpest annual moves came in 2022 and 2025: Net Margin tumbled 3848 bps in 2022, then soared 1000 bps in 2025.
Over 5 years, Net Margin stood at 12.77% in 2022, then plunged by 43 bps to 7.25% in 2023, then declined by 30 bps to 5.1% in 2024, then soared by 231 bps to 16.88% in 2025, then sank by 111 bps to 1.85% in 2026.
According to Business Quant data, Net Margin over the past three periods registered 1.85%, 16.88%, and 10.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Margin (Qtr)
1	Intuitive Surgical	132.71 Bn	127.50 Bn	1.96 Bn	28.46%
2	Becton Dickinson	51.57 Bn	50.71 Bn	2.32 Bn	7.59%
3	Alcon	35.52 Bn	34.17 Bn	1.68 Bn	-
4	Resmed	33.28 Bn	31.81 Bn	861.22 Mn	26.20%
5	Medline	27.86 Bn	25.18 Bn	2.22 Bn	1.81%
6	West Pharmaceutical Services	25.15 Bn	24.71 Bn	329.20 Mn	16.96%
7	Solventum	15.31 Bn	14.91 Bn	1.29 Bn	4.21%
8	Cooper Companies	14.86 Bn	14.72 Bn	735.40 Mn	-7.20%
9	Baxter International	13.63 Bn	11.48 Bn	1.03 Bn	4.26%
10	Embecta	319.59 Mn	101.39 Mn	153.30 Mn	7.77%

Download Data